Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
Clinical trial NCT01263353 · COMPLETED
Trial details
- NCT number
- NCT01263353
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.